Company news
Infield Minerals Corp (TSXV:IN) news
Infield Minerals Corp news releases on 6ix. Latest, Sep 19, 2019: InMed Pharmaceuticals Reports Fourth Quarter and Full Year Fiscal 2019 Financial Results…
Press releases — page 3
InMed Pharmaceuticals Reports Fourth Quarter and Full Year Fiscal 2019 Financial Results and Provides R&D and Business Update
September 19, 2019
InMed Pharmaceuticals to Report Fourth Quarter, and Full Year Fiscal 2019 Financial Results and Business Update on September 19, 2019
September 12, 2019
InMed Pharmaceuticals to Present at the H.C. Wainwright 21st Annual Global Investment Conference
September 3, 2019
InMed Pharmaceuticals to Attend the 2nd Annual International Cannabinoid-Derived Pharmaceuticals Summit
August 29, 2019
InMed Pharmaceuticals Appoints Bruce S. Colwill, CPA, CA as Chief Financial Officer and Announces other Leadership Changes
August 2, 2019
InMed Pharmaceuticals Appoints Catherine Sazdanoff to Board of Directors
July 2, 2019
InMed Pharmaceuticals Reports Third Quarter Fiscal 2019 Financial Results and Provides R&D and Business Update
May 15, 2019
InMed Pharmaceuticals to Report Third Quarter Fiscal 2019 Financial Results and Business Update on May 15, 2019
May 8, 2019
InMed Continues to Strengthen IP Portfolio for its Biosynthesis Platform Technology
March 18, 2019
InMed Pharmaceuticals Announces Transition to a Single Cannabinoid Investigational Drug Candidate - INM-755 - for its Epidermolysis Bullosa Program
March 13, 2019
InMed Pharmaceuticals to Present at the 31st Annual ROTH Conference on March 19, 2019
March 12, 2019
InMed Pharmaceuticals Appoints Dr. Steven M. Dinh to Scientific Advisory Board
March 6, 2019
InMed Pharmaceuticals Reports Second Quarter Fiscal 2019 Financial Results and Provides R&D and Business Update
February 12, 2019
InMed Pharmaceuticals to Report Second Quarter Fiscal 2019 Financial Results and Business Update on February 12, 2019
February 5, 2019
IIROC Trading Halt - ETWO.P
January 16, 2019
InMed Pharmaceuticals Announces the Appointment of Dr. Sazzad Hossain, PhD, MSc, as a Member of the Scientific Advisory Board and his Retirement as Chief Scientific Officer
January 11, 2019
InMed Pharmaceuticals to Present at Biotech Showcase 2019 on January 9, 2019
January 3, 2019
InMed Pharmaceuticals Receives Funding from the Government of Canada to Support Development of Novel Cannabinoid Biosynthesis Program
December 4, 2018
InMed Pharmaceuticals Reports First Quarter Fiscal 2019 Financial Results and Provides R&D and Business Update
November 12, 2018
InMed Pharmaceuticals to Report First Quarter Fiscal 2019 Financial Results and Business Update on November 12, 2018
November 5, 2018
InMed Pharmaceuticals Appoints Michael Woudenberg as Vice President, Chemistry, Manufacturing, and Controls
November 5, 2018
BTV Explores Tech Companies on Investors' Radar
November 1, 2018
InMed Pharmaceuticals to Present at BIO Investor Forum on October 17, 2018
October 10, 2018
InMed Pharmaceuticals Signs Agreement with the National Research Council of Canada for Cannabinoid Biofermentation Process Development and Scale-Up
October 3, 2018
InMed Pharmaceuticals Files PCT Patent Application for the Treatment of Pain with Cannabinoids
September 25, 2018
InMed Pharmaceuticals Reports Fourth Quarter and Full Year Fiscal 2018 Financial Results and Provides R&D and Business Update
September 13, 2018
InMed Pharmaceuticals Announces NSERC Grant to The University of British Columbia in Support of Collaborative R&D Work
September 11, 2018
InMed Files Patent Application for its Cannabinoid Biosynthesis Program
September 10, 2018
InMed Pharmaceuticals to Report Fourth Quarter, and Full Year Fiscal 2018 Financial Results and Business Update on September 13, 2018
September 7, 2018
InMed Pharmaceuticals to Present at the H.C. Wainwright 20th Annual Global Investment Conference
August 31, 2018
InMed to Present at the Canaccord Genuity 38th Annual Growth Conference
August 1, 2018
InMed Pharmaceuticals Announces the Closing of C$14.95 Million Bought Deal Financing including Full Exercise of Underwriter's Over-Allotment Option
June 21, 2018
InMed to Present at the 8th Annual LD Micro Invitational Conference
May 29, 2018
InMed Files Patent Application for INM-085 Glaucoma Program
May 14, 2018
InMed Reports Third Quarter Fiscal 2018 Financial Results and Provides Business Update
May 11, 2018
InMed Appoints Dr. Vikramaditya G. Yadav to Scientific Advisory Board
May 1, 2018
IIROC Trading Resumption - DLC; EONE.P; ETWO.P
April 24, 2018
IIROC Trading Halt - EONE.P; ETWO.P
April 18, 2018
InMed Pharmaceuticals Inc. Opens the Market
April 17, 2018
InMed Rings the Opening Bell at the Toronto Stock Exchange
April 17, 2018
InMed Announces Appointment of Joshua Blacher as Chief Business Officer
April 11, 2018
InMed Pharmaceuticals Announces Graduation to Toronto Stock Exchange
March 23, 2018
InMed Appoints Dr. Eric Hsu as Vice President, Preclinical Research and Development
March 13, 2018
InMed to Present at 30th Annual ROTH Capital Conference
March 12, 2018
InMed Announces Peer-Reviewed Publication in Drug Delivery and Translational Research
March 6, 2018
InMed Receives Conditional Approval to List on the Toronto Stock Exchange
March 2, 2018
InMed Closes Over-Subscribed C$9.4 Million Financing
January 4, 2018
CannabisNewsWire Announces Publication on Increased Investment Activity in Cannabis
December 22, 2017
CannabisNewsWire Announces Publication Discussing Biotech's Leading Role in the Cannabis Industry
December 21, 2017
InMed Announces Non-Brokered Private Placement
December 18, 2017